Keating Financial Advisory Services’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$35 Buy
+1
New +$39 ﹤0.01% 2535

Other funds holding TRAX

Keating Financial Advisory Services's TRAX Position: Q3 2026 in Review

Keating Financial Advisory Services opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 1 share worth $35. The stake represents ﹤0.01% of the portfolio and ranks #2535 among its holdings.

182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Keating Financial Advisory Services held 1 share of First Tracks Biotherapeutics worth $35 as of Q3 2026.
  • First Tracks Biotherapeutics was a new Keating Financial Advisory Services position in Q3 2026.
  • First Tracks Biotherapeutics made up ﹤0.01% of Keating Financial Advisory Services's portfolio in Q3 2026, its #2535 holding.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Keating Financial Advisory Services's 13F filing for Q3 2026, filed 12 Nov 2026.